Undervalued Medical Device & Instrument Stocks on NAS August 2024

August 31, 2024

Medical Devices & Instruments

Companies in the Medical Devices & Instruments industry develop, manufacture, and market medical and surgical equipment or instruments and supplies.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Medical Devices & Instruments stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
QDEL QuidelOrtho 42.25 60.86 44.05 889904 2835 0.00 0.0
NVCR NovoCure 19.44 24.00 23.46 952488 2094 0.00 0.0
AZTA Azenta 49.52 58.92 18.98 600651 2623 0.00 0.0
DXCM DexCom 69.34 81.16 17.04 5438905 28901 0.00 43.1
PODD Insulet 202.57 230.67 13.87 803695 14950 0.00 36.6
XRAY Dentsply Sirona 25.31 28.52 12.68 3233050 5204 2.37 0.0
ICUI ICU Medical 165.33 184.62 11.67 301321 4033 0.00 0.0
LIVN LivaNova 50.38 54.50 8.18 691045 2750 0.00 0.0
RGEN Repligen 150.82 162.61 7.82 782113 8511 0.00 0.0
HOLX Hologic 81.24 83.03 2.20 1611245 19210 0.00 27.7
All data provided as at market close August 29, 2024.

Company Details

QuidelOrtho

QDEL:NAS

Close Price

42.25

Our Valuation

60.86

% Difference

44.05

Market Cap ($M)

2835

P/E Ratio

0.0

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.

Access the stockcalc valuation


NovoCure

NVCR:NAS

Close Price

19.44

Our Valuation

24.00

% Difference

23.46

Market Cap ($M)

2094

P/E Ratio

0.0

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer.

Access the stockcalc valuation


Azenta

AZTA:NAS

Close Price

49.52

Our Valuation

58.92

% Difference

18.98

Market Cap ($M)

2623

P/E Ratio

0.0

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services.

Access the stockcalc valuation


DexCom

DXCM:NAS

Close Price

69.34

Our Valuation

81.16

% Difference

17.04

Market Cap ($M)

28901

P/E Ratio

43.1

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Insulet

PODD:NAS

Close Price

202.57

Our Valuation

230.67

% Difference

13.87

Market Cap ($M)

14950

P/E Ratio

36.6

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

Access the stockcalc valuation


Dentsply Sirona

XRAY:NAS

Close Price

25.31

Our Valuation

28.52

% Difference

12.68

Market Cap ($M)

5204

P/E Ratio

0.0

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation.

Access the stockcalc valuation


ICU Medical

ICUI:NAS

Close Price

165.33

Our Valuation

184.62

% Difference

11.67

Market Cap ($M)

4033

P/E Ratio

0.0

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022.

Access the stockcalc valuation


LivaNova

LIVN:NAS

Close Price

50.38

Our Valuation

54.50

% Difference

8.18

Market Cap ($M)

2750

P/E Ratio

0.0

UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiovascular and cardiopulmonary solutions (with surgical heart valves, heart-lung machines, and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses.

Access the stockcalc valuation


Repligen

RGEN:NAS

Close Price

150.82

Our Valuation

162.61

% Difference

7.82

Market Cap ($M)

8511

P/E Ratio

0.0

Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S.

Access the stockcalc valuation


Hologic

HOLX:NAS

Close Price

81.24

Our Valuation

83.03

% Difference

2.20

Market Cap ($M)

19210

P/E Ratio

27.7

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
QuidelOrtho and NovoCure are the most undervalued Medical Devices & Instruments stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-medical-device-instrument-stocks-nas-august-2024
QuidelOrtho $QDEL and NovoCure $NVCR are the most undervalued Medical Devices & Instruments stocks on the #NAS. See the full list: https://www.stockcalc.com/Blog/undervalued-medical-device-instrument-stocks-nas-august-2024
QuidelOrtho and NovoCure are the most undervalued Medical Devices & Instruments stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-medical-device-instrument-stocks-nas-august-2024

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.